receptor [l]. After uptake of the LDL-receptor complex 1. The capacity of low-density lipoprotein-cholesterol (40 ,ug/ml) to stimulate both the phosphoinositide cycle and the dislocation of the phospholipid-and calciumdependent protein kinase C activity from the cytosolic to the membranous compartment in human circulating lymphocytes has been studied.
INTRODUCTION
Circulating human lymphocytes have the capacity to produce a high-affinity low-density-lipoprotein (LDL) Correspondence: Professor W. Vetter, Department of Internal Medicine, University Hospital, CH-8091 -Zurich, Switzerland.
by -receptormediated endocytosis and-subsequent degradation of the complex, LDL-bound cholesteryl esters are hydrolysed [2] . The activity of 3-hydroxy-3-methylglutaryl-CoA reductase, a key enzyme in the regulation of intracellular cholesterol homoeostasis, has been reported to be controlled by protein kinase C (PKC), which is activated during stimulation of phosphoinositide turnover [3, 4] . Activation of this turnover by LDL, however, has been described in cultured rat vascular smooth muscle cells and in human platelets [5, 61 . Furthermore, mechanisms involving regulation of lipoprotein receptor synthesis, lipoprotein uptake and degradation, cholesteryl ester hydrolysis and synthesis of extracellular matrix have been discussed as potential sites of activity for calcium antagonists as anti-atherogenic drugs [7] . Thus the questions arose as to (1) whether LDL can stimulate the phosphoinositide cycle in peripheral lymophocytes, and (2) whether the phosphoinositide cycle is a target for calcium antagonists. We examine three problems using cultured human peripheral lymphocytes, which in previous experiments proved to be a feasible cell model [5] .
MATERIALS AND METHODS

Cell culture
Mononuclear cells were isolated in Ficoll-Paque gradients [8] from citrated blood obtained from healthy donors. Cells were cultured in FWMI 1640 medium containing 0.2% (w/v) bovine serum albumin for 3 days in the absence or presence of the appropriate radiolabel. In this method, monocytes adhere to the bottom of the flasks, whereas lymphocytes remain in suspension. Before stimulation, lymphocyte suspensions were centrifuged (150 g, 6 min, 22°C). The pellets were washed twice in FWMI 1640 medium. The cell viability, determined by Trypan Blue exclusion, was > 89%.
Phospholipid metabolism
To determine phosphoinositide breakdown, cells (10 x 10h/ml) were cultured in the presence of 10 pCi of 32P (carrier free)/ml. After stimulation of the cells (0.5 ml) by LDL (40 pg/ml) for various time intervals, the reaction was terminated by the addition of 1.8 ml of a solution of chloroform/methanol/HCI(10:20:0.2, by vol.). Phosphoinositides were extracted as described by Bligh & Dyer [9] . The solvents were evaporated under an N, stream. The residues were resuspended in 70 p1 of methanol/chloroform (1 : 1, v/v). In order to identify the phophatidylinositol bisphosphate (PtdInsP,) spot on h.p.t.1.c. plates, 3.5 pg of unlabelled PtdInsP, dissolved in 10 pl of chloroform/methanol ( l : l , v/v) was added to each sample. A portion (20 p l ) of the radiolabelled samples was applied to h.p.t.1.c. plates pre-coated with concentrating zone and with a solution of methanol/water (2 : 3, v/v) containing 54 mmol/l dipotassium oxalate. Chromatographic separation of phospholipids was carried out as described by Irvine el 01. [lo] . The PtdInsP, areas were visualized by charring them in a solution of 0.4 mol/l CuSO, and 0.7 mol/l H,PO,. Then the spots were scraped off and transferred to vials in order to determine radioactivity by liquid scintillation counting.
The formation of diacylglycerol (DAG) was determined by prelabelling lymphocytes with [3H]arachidonic acid (6 pCi/ml) for 3 days. After stimulation of the cells and subsequent extraction of the lipids as described by Bligh & Dyer [9] Inositol phosphates were labelled by cultivating lymphocytes in the presence of my0-[2-~H]inositol ( 3 pCi/ml) for 3 days in RPMI 1640 medium. After two washes, cells (5 X 1O6/ml) were cultured in RPMI 1640 medium for 1 h, followed by 15 min in RPMI 1640 containing 20 mmol/l LEI. LDL was added at various concentrations and time intervals. Controls were treated with aliquots of the incubation medium. The reactions were terminated by adding ice-cold 4.6 mol/l trichloroacetic acid to achieve a final concentration of 0.42 mol/l. Trichloroacetic acid was removed by extracting the samples with diethyl ether. Inositol trisphosphate (InsP,) was analysed by standardized ion-exchange chromatography as described by Berridge et al. [ 121.
PKC activity
Translocation of PKC activity in lymphocytes was determined by the method of Farrar & Anderson [13] . Cells were stimulated with either LDL (40 pg/ml) for various time intervals or phorbol 12-myristate 13-acetate (PMA; 100 ng/ml). The reaction was terminated by ultrasonication of the cells (40 W, 2 x 30 s, in an ice bath) with a microtip. The homogenate was reconstituted with 4 ml of ice-cold sample buffer (20 mmol/l Tris, pH 7.5, 0.33 mol/l sucrose, 2 mmol/l ethylenediaminetetra-acetate (disodium salt) and 1 mmol/l phenylmethanesulphonyl fluoride). Cytosol and particulate membrane fractions were prepared by centrifugation at 100 000 g for 60 min at 4°C. Membrane pellets were homogenized by ultrasonication (40 W, 15 s, in an ice bath) in 4 ml of sample buffer without sucrose. Then 40 pl of Nonidet-P4O were added to the homogenate and gently rocked for 30 min at 4°C. The fractions were passed through a column containing 1 ml of DE52 equilibrated with sample buffer without sucrose. Columns were washed with 10 ml of sample buffer and 0.5 ml of 0.08 mol/l NaCI. An additional 1.25 ml of 0.08 mol/l NaCl eluate was collected. Aliquots of 50 pl were assayed for PKC activity by adding 200 pl of 1 mmol/l CaCI,, 10 mmol/l Mg(CH,COO),, 100 pmol/l adenosine 5'-[y-32P]tripho~phate (30-60 c.p.m./pmol) and 50 pg of histone type 111-S with or without 5 pg of phosphatidylserine and 1 pg of dioleoylglycerol, as described in [13] . Data are expressed as PKC specific activity (pmol min-I mg-l of protein) attributed to activity stimulated by phospholipids.
Phospholipase C activity
A putative link between LDL-bound receptor and G-protein-mediated stimulation of phospholipase C in lymphocytes was examined by using pertussis toxin. Cells loaded with mr~yo-[2-~H]inositol (9 pCi/ml) were pretreated for 45 min with various concentrations of pertussis toxin before addition of LDL (40 pg/ml) for 1 min. The hydrolytic activity of phospholipase ' C was assessed by measuring the formation of InsP, [ 121.
Effect of calcium antagonists
In order to study the influence of calcium antagonists on the phosphoinositide cycle in lymphocytes, cells loaded with myo-[2-3HH]inositol for 3 days were preincubated for 30 min with various concentrations of verapamil, nifedipine, diltiazem, molsidomine, and flunarizine. Stock solutions of 1 mmol/l were prepared by dissolving verapamil and nifedipine in methanol/water (4: 1, v/v), diltiazem-HCI and flunarizine-HCI in water, and molsidomine in ethanol. The calcium blocker solutions were further diluted in RF' MI 1640. Then lymphocytes were stimulated with LDL (40 pglrnl) for 1 min. Formation of InsP, was estimated by the method of Berridge et a[. [ 121.
Preparation of LDL
LDL was prepared as described by Redgrave et al.
[ 141. The LDL fractions were dialysed twice against 150 mmol/l NaCl and 0.27 mmol/l of ethylenediaminetetraacetic acid (disodium salt), pH 7.0. Dialysates were concentrated by ultrafiltration and adjusted to 4 mg of protein/ml. The purity of LDL was examined by polyacrylamide-gel electrophoresis as described by Laemmli ~5 1 . DAG ( 6 ) and InsP, (c) was determined as described in the Materials and methods section. Points represent the m e a n s f s~ of two experiments performed in duplicate. 
Data
RESULTS
Effects of LDL on phosphoinositide cycle activity
Addition of LDL to peripheral lymphocytes precultured for 3 days in serum-free RPMI 1640 medium resulted in a rapid but transient stimulation of the phosphoinositide cycle (Fig. 1) . LDL (40 pg/ml) caused a clear 70% decrease in PtdInsP, formation within 1 min (Fig.  la) . In parallel, a four-fold increase in DAG formation was observed, with a maximal DAG formation rate at 2 min (Fig. 1 b) . Furthermore, LDL led to a 3.5-fold increase in InsP, formation within 1 min (Fig. lc) . The time course of both the Insf', and DAG formation was biphasic.
To determine the dose of LDL most effective in stimulating phosphoinositide cycle activity, lymphocytes were incubated with various concentrations of LDL. demonstrates that 40 yg of LDL/ml produced maximal InsP, formation. A further increase in the dose of LDL resulted in a return to InsP, formation levels found in the resting cell.
To examine LDL-stimulated PKC activity in lymphocytes, cells were stimulated with LDL (40 yg/ml) for various time intervals. As a positive control, PMA (100 nglml), which induces transposition of the PKC activity from the cytosolic to the membranous compartment, was used [13] . In unstimulated lymphocytes, a relatively high cytosol-associated PKC activity was found, with a correspondingly low PKC activity in the membranous fraction (Fig. 3) . Stimulation with LDL (40 yg/ml) for 1 min caused an eightfold rise in the membrane-associated PKC activity, whereas treatment of the cells with PMA (100 ng/ ml) resulted in an approximately tenfold increase in the membrane-associated PKC activity.
Inhibition of phosphoinositide cycle activity
Exposure of lymphocytes cultured in the presence of my0-[2-~HH]inositol to various concentrations of pertussis toxin resulted in an inhibition of the LDL-induced formation of InsP, in a dose-dependent manner (Table 1) . Pertussis toxin did not affect the basal activity of the phosphoinositide cycle.
To determine the influence of calcium antagonists on the phosphoinositide cycle activity in lymphocytes, cells cultured in the presence of my0-[2-~H]inositol were incubated for 30 min with various concentrations of verapamil, nifedipine, diltiazem, molsidomine or flunarizine, then LDL (40 yg/ml) was added for 1 min. Fig. 4(a) illustrates the inhibition of the LDL-induced formation of Time (min) Fig. 3 . Kinetics of cytosol-and membrane-associated PKC, activity. Lymphocytes were stimulated with either (a) LDL (40 yg/ml for various time intervals) or with (6) PMA (100 ng/ml) for 10 min. Experimental details of PKC activity determination are given in the Materials and methods section. Points are the m e a n s k s~ of three experiments.
[ Similar results were obtained with calcium-overload blockers. These blockers are classified as group B according to Van Zwieten [17] , and are known to have only moderate affinity for putative calcium channels. Among these compounds, 600 nmol/l flunarizine inhibited the LDL-stimulated formation of InsP, by more than 90%, and 600 nmol/l to 3 ymol/l molsidomine inhibited InsP, formation by 60% (Fig. 46) .
In order to compare the capacity of calcium antagonists to inhibit the IDL-induced formation of InsP, in lymphocytes, IC,, values were calculated. IC,, is the drug concentration which produces 50% of the maximal inhibition of InsP, formation. The corresponding IC,(, values were (in nmol/l, m e a n s k s~, ti =4): 15.3 k 2.1 for verapamil, 33.7 f 5.4 for diltiazem, 46.9 k 5.6 for nifedipine, 12.2 f 1.9 for flunarizine, and 15.8 k 2.7 for molsidomine.
DISCUSSION
This study has demonstrated the ability of LDL to stimulate the phosphoinositide cycle activity in circulating human lymphocytes. Besides its classical function [ 1, 2, 181, LDL appears to influence other cellular activities. The results of our investigation indicate that LDL is also Table 1 . Effect of pertussis toxin on the LDL-stimulated formation of InsP, in lymphocytes Lymphocytes prelabelled with my0-[2-~H]inositol(3 yCi/ ml) were treated with the indicated concentrations of pertussis toxin (PT) for 45 min. Thereafter, LDL (40 yg/ml) was added for 1 min. The reaction was terminated with 0.42 mol/l ice-cold trichloroacetic acid. I n s 4 was analysed as described by Berridge el af. [12] . Data (means f SD of triplicate determinations) are representative for a single experiment. In addition, studies with cholera toxin revealed inhibition of agonist-stimulated phosphoinositide breakdown in a macrophage and in a malignant T-cell line [24] . Based on these studies it was speculated that the G-protein linked to phospholipase C in certain leucocytes is a substrate for both cholera and pertussis toxins [24] . Since in the present study pertussis toxin affected the LDL-stimulated formation of InsP,, these findings may indicate that likewise in lymphocytes a G-protein could couple to phospholipase C. It is thus assumed that in peripheral lymphocytes, LDL appears to exert its effect on the phosphoinositide cycle via the mediation of a pertussis toxin-inhibitable Gprotein. The dose-dependent inhibitory effect of pertussis toxin on the LDL-mediated phosphoinositide cycle activity provides a further evidence for this assumption.
Calcium-channel blockers inhibited the LDL-stimulated formation of InsP, in peripheral lymphocytes. Interaction of calcium antagonists at sites other than calcium channels have been described, particularly in the adenosine 3' : S'-cyclic monophosphate (cyclic AMP) signal transducing system. Inhibition of a calmodulininsensitive chicken-heart cyclic AMP phosphodiesterase by verapamil and nimodipine with an ICso value of 9 pmol/l has been described [26] . Dixon plot analysis revealed competitive inhibition of the enzyme by verapamil. In another approach, rabbit platelet cyclic AMP phosphodiesterase was inhibited by diltiazem, verapamil and nifedipine, which also inhibited the adenosine 5'-diphosphate-induced aggregation of platelets [27] . Furthermore, radioligand-binding assays with verapamil, nifedipine and diltiazem, and subsequent determination of adenylate cyclase activity in lymphocytes, revealed that verapamil acts as a strong competitive B-receptor antagonist [28]. Obviously, calcium antagonists can also affect phosphoinositide breakdown, since inhibition of thrombin-stimulated phospholipase C was observed when blood'platelets were incubated with molsidomine [29] .
In conclusion these reports indicate that calcium antagonists can modulate membrane-located enzyme activities. Our findings of the inhibitory action of calcium antagonists on lymphocyte InsP, formation are consistent with these observations. However, as yet no precise ideas of the mechanisms by which calcium-channel blockers can affect enzyme activities on the cell surface have been presented.
